Check out your Company Bowl for anonymous work chats.
Fortrea Named a Leader in Everest Group’s Pharmacovigilance Operations PEAK Matrix® Assessment 2025
Fortrea x Emery Pharma: Advancing Drug-Drug Interaction Studies. Fortrea is excited to collaborate with Emery Pharma to deliver FDA-compliant, rifampin-driven drug-drug interaction (DDI) studies. Together, we are enabling rapid, lot-by-lot MNP impurity testing—helping sponsors safely use rifampin, an antibiotic commonly used in DDI studies, and stay compliant with evolving FDA guidance.
Anshul Thakral is starting as our new CEO! Anshul brings deep experience in healthcare and knows the CRO industry from the inside out, not only as an executive, but also as a customer. He has a strong track record of building companies and teams. Most important, Anshul brings a relentless focus on customers and a passion for patients. We’re excited to welcome Anshul to Fortrea!
